Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies

艾滋病指定恒河猴繁殖群种系免疫球蛋白库的群体基因分型

• 批准号: 10891040
• 负责人: Steven Edward Bosinger
• 金额: $ 40.76万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-05-01 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10891040
• 关键词: 2019-nCoV; AIDS Vaccines; Acquired Immunodeficiency Syndrome; Address; Alleles; Antibodies; Antigens; Applications Grants; Autologous; Benchmarking; Bioinformatics; Breeding; Catalogs; Communities; Complex; Data; Data Set; Databases; Development; Enrollment; Epitopes; Evolution; Foundations; Gene Targeting; Genetic; Genome; Genomics; Genotype; Germ-Line Mutation; Goals; HIV; HIV vaccine; Haplotypes; Human; Immunization; Immunoglobulin Genes; Immunoglobulins; Impairment; Individual; Knowledge; Longitudinal Studies; Macaca mulatta; Methodology; Modeling; Monkeys; Mutation; Outcome; Population; Population Heterogeneity; Positioning Attribute; Primates; Protocols documentation; R24; Reporting; Research; Resolution; Resources; T-Lymphocyte; Testing; Vaccinated; Vaccine Research; Vaccines; Variant; Virus; Work; cohort; combat; genetic information; genome resource; neutralizing antibody; novel; novel strategies; pandemic disease; pathogen; preclinical study; reference genome; response; tool; vaccine efficacy; vaccine response; vaccine strategy; vaccine trial; web-accessible

PROJECT SUMMARY A strategic priority for contemporary HIV vaccine research is the development of approaches to elicit broadly neutralizing antibodies (bNAbs) able to neutralize diverse strains of the virus. A cornerstone of bNAb discovery is the ability to conduct accurate, longitudinal studies of antibody evolution in HIV infected individual as they gain mutations and acquire neutralization activity. Currently, it is not possible to perform analogous antibody evolution tracing studies using rhesus macaques (RMs), due to a lack of defined immunoglobulin (IG) alleles. This is best exemplified by a recent study large scale vaccine study by our group in which we sequenced a de novo genome of a RM using long-read sequencing in order to obtain accurate assemblies of the IG loci. This reference significantly enhanced the accuracy of tracking the mutations from germline elicited by our vaccine strategies. This tool was critical in deciphering trajectories that led to either autologous neutralization or immunodominance and non-neutralizing responses. In other work, we have developed novel bioinformatics methodology (germline inference) to identify the unmutated germline antibody sequence from immunoglobulin repertoire. This work has led to identification of hundreds of novel inferred IG alleles. The goal of this R24 proposal is to build on these findings by characterizing the IG alleles and haplotypes in AIDS designated RMs at NHP primate centers that serve the major HIV vaccine stakeholders. Currently, the IG loci are poorly characterized in RMs, in part due to technical challenges. IG genotypes are not currently used as criteria when enrolling RMs into vaccine studies. In contrast, MHC genotyping of RMs has become standard practice for vaccine studies and is a core function in genetic management of NPRC RM colonies. The lack of genetic data on the RM IG loci is therefore a significant knowledge gap and impairs our ability to assess the evolution of antibodies in monkeys administered vaccines that aim to elicit neutralizing antibodies. The goal of this R24 proposal is to address this strategic need and build a resource in which this genetic information (IG allele sequence information, haplotype, and allele usage) is available to the HIV vaccine and NHP research communities.

项目总结